Article
The management of bone defect using long non-coding RNA as a potential biomarker for regulating the osteogenic differentiation process
1 Jan 2022
Abstract excerpt
Tissue engineered bone brings hope to the treatment of bone defects, and the osteogenic differentiation of stem cells is the key link. Inducing osteogenic differentiation of stem cells may be a potential approach to promote bone regeneration. In recent years, lncRNA has been studied in the field increasingly, which is believed can regulate cell cycle, proliferation, metastasis, differentiation and immunity,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
